ScholarLens Back to search
2022•Experimental HematologyRequires access

Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessments

Anita Tranberg Simonsen, Manja Meggendorfer, Marcus Høy Hansen, Line Nederby, Sarah Koch, Maria Hansen, Carina Agerbo Rosenberg, Wolfgang Kern, Charlotte Guldborg Nyvold, Anni Aggerholm, Torsten Haferlach, Hans Beier Ommen

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: clone (Java method), Somatic evolution in cancer, Minimal residual disease, Myeloid leukemia, CD38, Oncology, Biology, Leukemia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessments — Research Paper | ScholarLens